Literature DB >> 1684350

HLA DQ alpha typing of forensic specimens by amplification restriction fragment polymorphism (ARFP) analysis.

C S Harrington1, V Dunaiski, K E Williams, C Fowler.   

Abstract

The alleles present at the HLA DQ alpha locus may be typed by either allele specific oligonucleotide (ASO) probing or by restriction mapping, referred to here as amplification restriction fragment polymorphism (ARFP) analysis. ASO typing relies upon hybridization principles, whereas ARFP typing relies upon restriction site analysis. Dot-blot ASO typings which are of doubtful interpretation may be directly checked by ARFP analysis. Aliquots of the PCR products amplified using the commercial Amplitype HLA DQ alpha system are digested with suitable restriction endonucleases. Electrophoresis, blotting and detection of biotin-labelled restriction fragments provides a sensitive and robust typing method suited to forensic analysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684350     DOI: 10.1016/0379-0738(91)90215-5

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  Distribution of HLA DQA.1 alleles in New Zealand Caucasian, Maori and Pacific Islander populations. Comparison with other population studies.

Authors:  P Stringer; C M Triggs; L C Baldwin; L M Melia; M G Savill
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

2.  Population data of the HLA DQ alpha locus in Dutch Caucasians. Comparison with other population studies.

Authors:  A D Kloosterman; B Budowle; E L Riley
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

3.  The distribution of HLA DQA1 and D1S80 (pMCT118) alleles and genotypes in the populations of Galicia and central Portugal.

Authors:  M V Lareu; I Muñoz; C Pestoni; M S Rodriguez; C Vide; A Carracedo
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

4.  HLA-DQA1 in autochthonous Basques: description of a genocline for the DQA1*0201 allele in Europe.

Authors:  M Iriondo; C Manzano; C de la Rúa
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.